Inge van der Werf

470 total citations
17 papers, 168 citations indexed

About

Inge van der Werf is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Inge van der Werf has authored 17 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Hematology and 5 papers in Cancer Research. Recurrent topics in Inge van der Werf's work include Acute Myeloid Leukemia Research (8 papers), RNA Research and Splicing (8 papers) and RNA modifications and cancer (3 papers). Inge van der Werf is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), RNA Research and Splicing (8 papers) and RNA modifications and cancer (3 papers). Inge van der Werf collaborates with scholars based in Netherlands, United States and Germany. Inge van der Werf's co-authors include Catriona Jamieson, Bernadette A. Chua, Robert Signer, Jacqueline Cloos, Torsten Haferlach, Michael D. Burkart, Gert J. Ossenkoppele, Larisa Balaian, Peggy Wentworth and Jeroen J. W. M. Janssen and has published in prestigious journals such as Blood, Cancer Research and FEBS Letters.

In The Last Decade

Inge van der Werf

14 papers receiving 167 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inge van der Werf Netherlands	7	124	46	37	20	20	17	168
Courtney E. Hershberger United States	7	176 1.4×	63 1.4×	36 1.0×	21 1.1×	12 0.6×	20	237
Hong Yao China	7	76 0.6×	59 1.3×	32 0.9×	28 1.4×	13 0.7×	22	137
Luisa Ladel United States	7	135 1.1×	65 1.4×	41 1.1×	13 0.7×	29 1.4×	15	204
Laury Poulain France	4	76 0.6×	55 1.2×	20 0.5×	9 0.5×	9 0.5×	6	132
Bettina Moehrle Germany	4	68 0.5×	63 1.4×	17 0.5×	15 0.8×	15 0.8×	5	127
M’Boyba Diop France	8	98 0.8×	74 1.6×	29 0.8×	38 1.9×	19 0.9×	14	175
Sofia Bakogianni United States	2	186 1.5×	39 0.8×	25 0.7×	6 0.3×	16 0.8×	2	208
Christina Sternberg Austria	6	145 1.2×	25 0.5×	10 0.3×	18 0.9×	33 1.6×	6	188
Manuela Romano France	2	77 0.6×	17 0.4×	28 0.8×	14 0.7×	6 0.3×	2	119
Faisal Basheer Pakistan	5	121 1.0×	86 1.9×	53 1.4×	12 0.6×	15 0.8×	22	174

Countries citing papers authored by Inge van der Werf

Since Specialization

Citations

This map shows the geographic impact of Inge van der Werf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge van der Werf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge van der Werf more than expected).

Fields of papers citing papers by Inge van der Werf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge van der Werf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge van der Werf. The network helps show where Inge van der Werf may publish in the future.

Co-authorship network of co-authors of Inge van der Werf

This figure shows the co-authorship network connecting the top 25 collaborators of Inge van der Werf. A scholar is included among the top collaborators of Inge van der Werf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge van der Werf. Inge van der Werf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Pham, Jessica, Shuvro P. Nandi, Larisa Balaian, et al.. (2025). Space-associated stem cell hallmarks of aging and resilience in astronauts. Cell stem cell. 32(12). 1886–1903.e7. 1 indexed citations

Werf, Inge van der, et al.. (2024). RNA Modifications Shape Hematopoietic Stem Cell Aging: Beyond the Code. FEBS Letters. 598(22). 2774–2775. 1 indexed citations

Crews, Leslie, Wenxue Ma, Luisa Ladel, et al.. (2023). Reversal of malignant ADAR1 splice isoform switching with Rebecsinib. Cell stem cell. 30(3). 250–263.e6. 40 indexed citations

Middelkamp, Sjors, Freek Manders, Markus J. van Roosmalen, et al.. (2023). Comprehensive single-cell genome analysis at nucleotide resolution using the PTA Analysis Toolbox. Cell Genomics. 3(9). 100389–100389. 7 indexed citations

Werf, Inge van der, Larisa Balaian, Luisa Ladel, et al.. (2023). Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells. Cell Reports Medicine. 4(3). 100962–100962. 18 indexed citations

Werf, Inge van der, Marijn A. Vermeulen, Marta Fiocco, et al.. (2023). Spatial Technologies Reveal the Immune Landscape of Pediatric Acute Myeloid Leukemia. Blood. 142(Supplement 1). 2959–2959.

Werf, Inge van der, et al.. (2023). Single-Cell Whole-Genome Sequencing after Chemotherapeutic Treatment Reveals Cell Type-Specific Mutational Burdens. Blood. 142(Supplement 1). 4136–4136. 1 indexed citations

Werf, Inge van der, et al.. (2022). Deep learning-based cell segmentation identifies T cell infiltration and spatial distribution in de novo pediatric AML. Klinische Pädiatrie. 234(3). 186–187. 1 indexed citations

Donohoe, Mary E., George F. Widhopf, Emanuela M. Ghia, et al.. (2022). Cirmtuzumab (Zilovertamab) Eliminates ROR1 Positive Leukemia Stem Cells By Blocking Niche Dependent ROR1/WNT5a Signaling. Blood. 140(Supplement 1). 3356–3357.

10.

Wojtuszkiewicz, Anna, Inge van der Werf, Stephan Hütter, et al.. (2021). Maturation State-Specific Alternative Splicing in FLT3-ITD and NPM1 Mutated AML. Cancers. 13(16). 3929–3929. 4 indexed citations

11.

Werf, Inge van der, Friso Calkoen, Stefan Nierkens, et al.. (2021). Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward. Cancers. 13(17). 4364–4364. 6 indexed citations

12.

Werf, Inge van der, Anna Wojtuszkiewicz, Huilan Yao, et al.. (2021). SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia. Leukemia. 35(9). 2698–2702. 8 indexed citations

13.

Werf, Inge van der, Anna Wojtuszkiewicz, Manja Meggendorfer, et al.. (2021). Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification. Blood Advances. 5(17). 3254–3265. 23 indexed citations

14.

Chua, Bernadette A., Inge van der Werf, Catriona Jamieson, & Robert Signer. (2020). Post-Transcriptional Regulation of Homeostatic, Stressed, and Malignant Stem Cells. Cell stem cell. 26(2). 138–159. 56 indexed citations

15.

Werf, Inge van der, Cayla Mason, Jacqueline Cloos, et al.. (2020). Selective Targeting of Alternative Splicing Deregulation in Pediatric Acute Myeloid Stem and Progenitor Cells. Blood. 136(Supplement 1). 8–8.

16.

Werf, Inge van der, Larisa Balaian, Cayla Mason, et al.. (2020). Abstract 469: Selective targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells. Cancer Research. 80(16_Supplement). 469–469. 1 indexed citations

17.

Werf, Inge van der & Jacqueline Cloos. (2015). Involvement of SRSF1 in Alternative Splicing of FPGS and Methotrexate Resistance in Children with Acute Lymphoblastic Leukemia. TU Delft Library (Tu Delft). 1(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact